Leishmania-induced tyrosine phosphorylation in the host macrophage and its implication to infection.
Tyrosine phosphorylation is an important mechanism of cell regulation and has been recently implicated in defense strategies against a variety of pathogens. We have investigated the involvement of protein tyrosine kinase activity in the Leishmania attachment, invasion and survival within macrophages, as well as promastigote ability to trigger tyrosine phosphorylation, which could contribute to leishmanicidal activity. Treatment of murine macrophage monolayers with genistein, herbimycin A, tyrphostin 25 or staurosporine prior to infection decreased parasite invasion in a dose-dependent manner. Contrary, addition of sodium orthovanadate, a protein tyrosine phosphatase inhibitor, phosphotyrosine and p-nitrophenyl phosphate to the interaction medium, significantly increased parasite binding and internalization, whereas phosphoserine and phosphothreonine had no effect. The phosphatase activity of intact promastigotes was greater than that of macrophages. Western blot analysis revealed tyrosine-phosphorylated bands from 198 to 28 kDa following macrophage challenge with promastigotes. Uninfected macrophages displayed no detectable tyrosine phosphorylated proteins, possibly indicating an inducible process, while in parasites it was constitutive, as seen by the presence of 42, 40 and 35 kDa phosphoproteins on the Leishmania lysates. Immunofluorescence and immunogold detection of phosphotyrosine residues in some promastigote-macrophage attachment areas, but not in the vicinity of ingested parasites, suggest that Leishmania-induced tyrosine phosphorylation is an early, local and short-lived event. Genistein treatment of Leishmania-infected cells significantly enhanced the parasite burden. This antagonist also diminished nitric oxide production in resting and interferon gamma/lipopolysaccharide-activated infected macrophages, which may account for the increased parasite survival. We propose that protein tyrosine kinase-linked pathways regulate the Leishmania promastigote invasion and the macrophage microbicidal activity.
Martiny
A
A
Programa de Biologia Celular e Parasitologia, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Brazil.
Vannier-Santos
M A
MA
Borges
V M
VM
Meyer-Fernandes
J R
JR
Assreuy
J
J
Cunha e Silva
N L
NL
de Souza
W
W
D000818:Animals; D016227:Benzoquinones; D004305:Dose-Response Relationship, Drug; D019084:Fluorescent Antibody Technique, Indirect; D019833:Genistein; D007150:Immunohistochemistry; D007529:Isoflavones / Q000494:pharmacology; D047029:Lactams, Macrocyclic; D007896:Leishmaniasis / Q000201:enzymology* / Q000276:immunology; D008262:Macrophage Activation; D017737:Macrophages, Peritoneal / Q000201:enzymology* / Q000469:parasitology*; D008297:Male; D051379:Mice; D008854:Microscopy, Electron; D009570:Nitriles / Q000494:pharmacology; D009943:Organophosphorus Compounds / Q000494:pharmacology; D010766:Phosphorylation / Q000187:drug effects; D019000:Phosphotyrosine / Q000494:pharmacology; D017027:Protein Tyrosine Phosphatases / Q000037:antagonists & inhibitors / Q000502:physiology; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D011809:Quinones / Q000494:pharmacology; D017828:Rifabutin / Q000031:analogs & derivatives; D019311:Staurosporine / Q000494:pharmacology; D020032:Tyrphostins; D014638:Vanadates / Q000494:pharmacology
D016227:Benzoquinones; D007529:Isoflavones; D047029:Lactams, Macrocyclic; D009570:Nitriles; D009943:Organophosphorus Compounds; D011809:Quinones; D020032:Tyrphostins; C079836:tyrphostin 25; D017828:Rifabutin; D019000:Phosphotyrosine; D014638:Vanadates; C020754:herbimycin; D019833:Genistein; D011505:Protein-Tyrosine Kinases; D017027:Protein Tyrosine Phosphatases; D019311:Staurosporine